SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-21-026289
Filing Date
2021-05-11
Accepted
2021-05-11 07:30:44
Documents
72
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q sdgr-10q_20210331.htm 10-Q 2595015
2 EX-31.1 sdgr-ex311_10.htm EX-31.1 21757
3 EX-31.2 sdgr-ex312_7.htm EX-31.2 21778
4 EX-32.1 sdgr-ex321_6.htm EX-32.1 5779
5 EX-32.2 sdgr-ex322_8.htm EX-32.2 5932
  Complete submission text file 0001564590-21-026289.txt   7364380

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT sdgr-20210331.xml EX-101.INS 1173902
7 XBRL TAXONOMY EXTENSION SCHEMA sdgr-20210331.xsd EX-101.SCH 61882
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sdgr-20210331_cal.xml EX-101.CAL 52300
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sdgr-20210331_def.xml EX-101.DEF 237928
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE sdgr-20210331_lab.xml EX-101.LAB 455053
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sdgr-20210331_pre.xml EX-101.PRE 352906
Mailing Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036
Business Address 120 WEST 45TH STREET 17TH FLOOR NEW YORK NY 10036 503-299-1150
Schrodinger, Inc. (Filer) CIK: 0001490978 (see all company filings)

IRS No.: 954284541 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39206 | Film No.: 21909625
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences